1. Home
  2. PRLD vs CPBI Comparison

PRLD vs CPBI Comparison

Compare PRLD & CPBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRLD
  • CPBI
  • Stock Information
  • Founded
  • PRLD 2016
  • CPBI 2023
  • Country
  • PRLD United States
  • CPBI United States
  • Employees
  • PRLD N/A
  • CPBI N/A
  • Industry
  • PRLD Medicinal Chemicals and Botanical Products
  • CPBI
  • Sector
  • PRLD Health Care
  • CPBI
  • Exchange
  • PRLD Nasdaq
  • CPBI Nasdaq
  • Market Cap
  • PRLD 50.1M
  • CPBI 58.1M
  • IPO Year
  • PRLD 2020
  • CPBI N/A
  • Fundamental
  • Price
  • PRLD $0.89
  • CPBI $14.55
  • Analyst Decision
  • PRLD Strong Buy
  • CPBI
  • Analyst Count
  • PRLD 2
  • CPBI 0
  • Target Price
  • PRLD $4.50
  • CPBI N/A
  • AVG Volume (30 Days)
  • PRLD 137.5K
  • CPBI 1.3K
  • Earning Date
  • PRLD 05-06-2025
  • CPBI 01-01-0001
  • Dividend Yield
  • PRLD N/A
  • CPBI N/A
  • EPS Growth
  • PRLD N/A
  • CPBI 29.70
  • EPS
  • PRLD N/A
  • CPBI 1.62
  • Revenue
  • PRLD $7,000,000.00
  • CPBI $18,546,000.00
  • Revenue This Year
  • PRLD N/A
  • CPBI N/A
  • Revenue Next Year
  • PRLD N/A
  • CPBI N/A
  • P/E Ratio
  • PRLD N/A
  • CPBI $9.00
  • Revenue Growth
  • PRLD N/A
  • CPBI 13.73
  • 52 Week Low
  • PRLD $0.61
  • CPBI $9.96
  • 52 Week High
  • PRLD $6.80
  • CPBI $15.50
  • Technical
  • Relative Strength Index (RSI)
  • PRLD 51.42
  • CPBI 43.62
  • Support Level
  • PRLD $0.77
  • CPBI $14.53
  • Resistance Level
  • PRLD $1.00
  • CPBI $14.80
  • Average True Range (ATR)
  • PRLD 0.11
  • CPBI 0.10
  • MACD
  • PRLD -0.01
  • CPBI -0.04
  • Stochastic Oscillator
  • PRLD 37.18
  • CPBI 4.26

About PRLD Prelude Therapeutics Incorporated

Prelude Therapeutics Incorp is a clinical stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet needs. The company's pipeline includes four candidates currently in clinical development: PRT1419, a potent, selective inhibitor of MCL1; PRT2527, a potent and selective CDK9 inhibitor, PRT3645, a next-generation CDK4/6 inhibitor, and PRT3789 a first-in-class SMARCA2/BRM protein degrader.

About CPBI Central Plains Bancshares Inc.

Central Plains Bancshares Inc operates as the bank holding company for Home Federal Savings and Loan Association of Grand Island that provides mortgage, consumer, commercial real estate, and commercial loans, The bank business consists primarily of accepting deposits from the general public and investing those deposits, together with funds generated from operations, in one- to four-family residential mortgage loans secured by properties located in our primary market area, as well as commercial real estate loans.

Share on Social Networks: